Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Can Big Pharma Save Biotech Investors?

Executive Summary

Want to know how bad off small biotechs are these days? Investment bankers are so desperate to unload companies, they've taken to calling on corporate development departments with lists of "wounded animals" - those companies with just a few months of cash remaining, according to a business development head at a big pharmaceutical company
Advertisement

Related Content

Merck Continues Looking For The “Right” Biotech Buying Opportunity
Wyeth Re-enters Appetite Suppression Game With Thiakis Acquisition
New Funding Source For Cash-Strapped BioPharma
With Five Deals In Two Months, TorreyPines Scrambling To Preserve A Future
With Innovative Purdue Deal, Infinity Finds Shelter From The Storm
Osiris/Genzyme Put Stem Cells On The Deal Map
Exelixis Hopes To Avoid The Whole Capital Mess By Peddling Its Pipeline
GlaxoSmithKline Looks To Revamp U.S. Operations In Tough Environment
GlaxoSmithKline Looks To Revamp U.S. Operations In Tough Environment
Prestwick Buyout Scores Huntington’s Drug For Biovail
Advertisement
UsernamePublicRestriction

Register

PS050384

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel